Cite
HARVARD Citation
Hurwitz, H. et al. (n.d.). 2141 Safety outcomes from 3 observational or phase 4 studies of bevacizumab (Bev) in metastatic colorectal cancer (mCRC). European journal of cancer. pp. S379-S380. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Hurwitz, H. et al. (n.d.). 2141 Safety outcomes from 3 observational or phase 4 studies of bevacizumab (Bev) in metastatic colorectal cancer (mCRC). European journal of cancer. pp. S379-S380. [Online].